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Reduction of Cesarean Section Surgical Site Infections (SSI): 
Progression and Implementation of Evidence Based Practice 
Purpose Statement 
To improve cesarean section patient experience by 
reduction of postoperative SSI 
Synthesis of Evidence 
•“SSIs are serious operative complications that occur 
in approximately 2% of surgical procedures and 
account for some 20% of health care-associated 
infections” (De Lissovy et al., 2009, p. 387). 
•Ancef 3g recommended for weight >120kg 
(American College of Obstetricians & Gynecologists, 
2011). 
•Chlorhexidine gluconate (CHG) effective for 
reduction in number bacteria on the skin. 
Standardized patient education helps improve 
compliance and efficacy of CHG product. 
• Silver silicone foam boarder re-sealable dressing 
(foam Ag dressing) provides extended broad-spectrum 
antimicrobial activity, along with bacterial and viral 
barrier. 
•Mayo Clinic Collaborative evidence indicated 50% 
reduction in SSIs following implementation of closing 
protocol (Robbins & Bakkum-Gamez, 2014). 
Evidence Based Practice Change Discussion/Conclusion 
•Surgical Care Improvement Project (SCIP) 
measures >90%. 
•Consideration of changing from CHG wipes to 
CHG liquid due to cost of wipes at $4.66/patient ; a 
department expense.  CHG liquid is available over 
the counter costing $4-$7. 
•Pre procedure call made to scheduled cesarean 
section patient to educate on use of CHG and 
prevention measures prior to arrival at hospital,  
90% compliance identified with CHG wipe use. 
•Learned that CHG and the fenestrated drape do 
not adhere; lead to standardization of iodine 
infused drape.  
•Costs of foam Ag dressing $18K (all patients) 
compared to average infection cost of $20K/one 
patient. 
• Standardized patient education developed for 
CHG bathing and foam Ag dressing. 
•Time for implementation of closing trays adds 60 
to 120 seconds to each case. 
•Review of FY2015 superficial infections  
identified concerns with antibiotic dosing post 
procedure, patient education related to wound 
dressings and cultural barriers,  and pannus yeast 
development driving future EBP initiatives. 
St. Cloud Hospital , St. Cloud, Minnesota 
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Background 
•A cesarean section SSI may affect a woman 
physically, mentally, and/or emotionally while adding 
to increased healthcare costs and effecting the 
bonding of mother and child. 
•CentraCare Health is committed to patient 
experience; providing the highest quality of care and 
resources to improve health, cost, patient safety, and 
equity of care for all. 
•Beginning July 2012, identified increase in overall 
incidence of SSIs following cesarean sections. 
•To decrease the incidence rate of SSIs following a 
cesarean section, hospitals need to assess current 
infection prevention practices and implement 
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• Spring: Reduction in OR traffic (traffic control) 
• September: Implement preoperative use of CHG wipes in the home for 
scheduled and before all cesarean sections within the hospital 
• Fall: Antibiotic dosing at cord clamping 
• Standardize OR environmental cleaning 
• Multidisciplinary team meeting case reviews 
• April-May:  CHG Prep use in the OR (formally used Iodine paint) 
• May 2015: CHG showering and wipe use for unplanned cesarean sections 
• May: Foam Ag dressing standard  for all cesarean sections 
• June: Exclusive use of iodine infused drape 
• July: Trial closing trays via Plan-Do-Study-Act (PDSA) model 
• August: Re-dosing of antibiotics if blood loss > 1500mL or case longer than 
half life of pre-operative antibiotics 
• Glucose control non-diabetic patient 
• Pre and post surgical multidisciplinary briefings (April 2016) 
• Yeast and skin moisture 
• Panniculus retractors 
• OR environmental cleaning (Time and Technique) 
2016 
• Emphasis on proper OR attire and traffic control 
• February: Weight based dosing of  pre-procedure antibiotics 
• October: Standardize wound care; criteria for foam Ag dressing use 
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CSEC SSI Rate 
SSI Rate Deep/Organ SSI Rate NSHN Pooled Mean 
• Spring: OR traffic control 
• September: Implement CHG wipe use 
in the home for scheduled procedures 
and before all within the hospital 
• Fall: Antibiotic dosing at cord 
clamping 
• Glucose control non-diabetic patient 
• Yeast and  skin moisture 
• Paniculus retractors 
• April-May:  CHG Prep use in the OR 
(formally used Duraprep) 
• May 2015: CHG showering and wipe 
use 
• May: Foam Ag dressing standard  for 
all procedures 
• June Exclusive use of Ioban Drape 
• July: Trial closing trays via PDSA 
model 
• August: Re-dosing of antibiotics if 
blood loss > 1500mL or case longer 
than half life of pre-operative antibiotics 
2016 
• February: Weight based 
dosing of  pre-
procedure antibiotics 
• October: Standardized 
post-operative incision 
care 
• OR attire 
2016 








before all within 
the hospital 
• Fall: Antibiotic 




• April-May:  CHG Prep use 
in the OR (formally used 
Duraprep) 
• May 2015: CHG showering 
and wipe use 
• May: Foam Ag dressing 
standard  for all 
procedures 
• June Exclusive use of 
Ioban Drape 
• July: Trial closing trays via 
PDSA model 
• August: Re-dosing of 
antibiotics if blood loss > 
1500mL or case longer 








operative incision care 
•OR attire 
• Glucose control non-
diabetic patient 
• Yeast and  skin moisture 
• Paniculus retractors 
